期刊文献+

HSVECs血管生成模型和HUVECs血管生成模型的比较

HSVECs and HUVECs angiogenesis model in vitro
原文传递
导出
摘要 首次利用人隐静脉内皮细胞(HSVECs)在体外建立血管生成模型,并与脐静脉内皮细胞(HUVECs)模型进行比较.在不加入任何生长因子的条件下,在三维胶原系统中经过3 d的培养,HSVECs能形成毛细血管样网状结构.genistein是一种酪氨酸酶抑制剂,它能影响毛细血管网的形成.与HUVECs模型比较两者存在明显的差异性.HSVECs在体外三维模型中能形成一种变异型的毛细血管样网状结构. HSVECs angiogenesis model was first developed and compared with HUVECs angiogenesis model. HSVECs and HUVECs were separately sandwiched into the 3-D collagen gels to culture the angiogenesis model in vitro; the anti-angiogenic effects of genistein was assessed in this system. HSVECs have the capacity to form capillary-like structures in this model, the organization process was slower than HUVECs angiogenesis model. This new HSVEC angiogenesis model has been proved to be as a anti-angiogenic screening model.
出处 《云南大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第5期457-460,共4页 Journal of Yunnan University(Natural Sciences Edition)
基金 云南大学理(工)科校级科研项目资助(K1059069)
关键词 内皮细胞 血管生成 体外模型 HSVECs angiogenesis model capillary-like tubes
  • 相关文献

参考文献12

  • 1吕家本,魏红军,蒋定文,于志洁.用CAM技术评价鲨鱼软骨提取物抑制新生血管生长的活性[J].中国生化药物杂志,1998,19(4):173-175. 被引量:8
  • 2RISAU W. Mechanisms of angiogenesis[J].Nature, 1997,386:671-674.
  • 3FOLKMAN J. Angiogenesis in cancer, vascular, rheumatoid and other disease[J]. Nature Med, 1995, ( 1 ) :27-31.
  • 4FOLKMAN J, HAUDENSCHILD C. Angiogenesis in vitro [J]. Nature, 1980,288: 551-556.
  • 5GIMBRONE M A, COTA R S,FOLKMAN J.Human vascular endothelial cell in culture, growth and DNA synthesis [J] .J Cell Biol, 1974,60:673-684.
  • 6MONTESANO R,VASSALLI J D,BAIRD A,et al. Basic fibroblast growth factor induces angiogenesis in vitro[J]. Proc Natl Acad Sci USA, 1986,83:7 297-7 301.
  • 7黄煜伦,周幽心,周岱,许期年,叶明,孙成法,杜子威.雷公藤红素抑制血管生成的实验研究[J].中华肿瘤杂志,2003,25(5):429-432. 被引量:74
  • 8王玮琴,周慧君,陈欢欢,吴国东.青蒿琥酯抑制新生血管生成的作用[J].中国药理学与毒理学杂志,2004,18(1):32-36. 被引量:22
  • 9GROSIOS K, HOLWELL S E, MCGOWN A T, et al. In vivo and in vitro evaluation of combretastatin A- 4 and its sodium phosphate prodrug[J]. Br J Cancer, 1999,81(8): 1 318- 1327.
  • 10RUGGERI B,SINGH J,GINGRICH D,et al. CEP- 7055:a novel, orally active pan inhibitor of VEGF receptor tyrosine kinase with potent antiangiogenic activity and antitumor efficacy in preclinical models[J]. Cancer Res,2003,63(18) :5 978-5 991.

二级参考文献3

共引文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部